Assistance Publique-Hôpitaux de Paris, Department of Imaging and Interventional Radiology, Hôpital Tenon, 75020, Paris, France.
Department of Radiology, Montpellier Cancer Institute and Montpellier Research Cancer Institute, PINKcc Lab, U1194, 34090, Montpellier, France.
Diagn Interv Imaging. 2024 Oct;105(10):386-394. doi: 10.1016/j.diii.2024.05.004. Epub 2024 Jun 14.
The purpose of this study was to evaluate the contribution of apparent diffusion coefficient (ADC) analysis of the solid tissue of adnexal masses to optimize tumor characterization and possibly refine the risk stratification of the O-RADS MRI 4 category.
The EURAD cohort was retrospectively analyzed to select all patients with an adnexal mass with solid tissue and feasible ADC measurements. Two radiologists independently measured the ADC values of solid tissue, excluding necrotic areas, surrounding structures, and magnetic susceptibility artifacts. Significant differences in diffusion quantitative parameters in the overall population and according to the morphological aspect of solid tissue were analyzed to identify its impact on ADC reliability. Receiver operating characteristics curve (ROC) was used to determine the optimum cutoff of the ADC for distinguishing invasive from non-invasive tumors in the O-RADS MRI score 4 population.
The final study population included 180 women with a mean age of 57 ± 15.5 (standard deviation) years; age range: 19-95 years) with 93 benign, 23 borderline, and 137 malignant masses. The median ADC values of solid tissue was greater in borderline masses (1.310 × 10 mm/s (Q1, Q3: 1.152, 1.560 × 10 mm/s) than in benign masses (1.035 × 10 mm/s; Q1, Q3: 0.900, 1.560 × 10 mm/s) (P= 0.002) and in benign tumors compared by comparison with invasive masses (0.850 × 10 mm/s; Q1, Q3: 0.750, 0.990 × 10 mm/s) (P < 0.001). Solid tissue corresponded to irregular septa or papillary projection in 18.6% (47/253), to a mural nodule or a mixed mass in 46.2% (117/253), and to a purely solid mass in 35.2% (89/253) of adnexal masses. In mixed masses or masses with mural nodule subgroup, invasive masses had a significantly lower ADC (0.830 × 10 mm/s (Q1, Q3: 0.738, 0.960) than borderline (1.385; Q1, Q3: 1.300, 1.930) (P= 0.0012) and benign masses (P= 0.04). An ADC cutoff of 1.08 × 10 mm/s yielded 71.4% sensitivity and 100% specificity for identifying invasive lesions in the mixed or mural nodule subgroup with an AUC of 0.92 (95% confidence interval: 0.76-0.99).
ADC analysis of solid tissue of adnexal masses could help distinguish invasive masses within the O-RADS MRI 4 category, especially in mixed masses or those with mural nodule.
本研究旨在评估附件肿块实性组织的表观扩散系数(ADC)分析对肿瘤特征的贡献,以优化肿瘤特征描述并可能细化 O-RADS MRI 4 类别的风险分层。
回顾性分析 EURAD 队列,以选择所有具有实性组织且可行 ADC 测量的附件肿块患者。两位放射科医生独立测量实性组织的 ADC 值,排除坏死区域、周围结构和磁化率伪影。分析总体人群和实性组织形态学方面的扩散定量参数的显著差异,以确定其对 ADC 可靠性的影响。使用受试者工作特征曲线(ROC)确定 ADC 在 O-RADS MRI 评分 4 人群中区分浸润性和非浸润性肿瘤的最佳截断值。
最终研究人群包括 180 名女性,平均年龄为 57 ± 15.5 岁(标准差);年龄范围:19-95 岁),其中 93 例为良性,23 例为交界性,137 例为恶性肿块。交界性肿块的实性组织 ADC 值中位数(1.310×10mm/s(Q1,Q3:1.152,1.560×10mm/s)高于良性肿块(1.035×10mm/s;Q1,Q3:0.900,1.560×10mm/s)(P=0.002),且高于良性肿瘤与侵袭性肿瘤(0.850×10mm/s;Q1,Q3:0.750,0.990×10mm/s)(P<0.001)。实性组织在 18.6%(47/253)的病例中对应不规则的隔室或乳头状突起,在 46.2%(117/253)的病例中对应壁结节或混合肿块,在 35.2%(89/253)的病例中对应纯实性肿块。在混合性肿块或壁结节亚组中,侵袭性肿块的 ADC 值明显较低(0.830×10mm/s(Q1,Q3:0.738,0.960)低于交界性(1.385;Q1,Q3:1.300,1.930)(P=0.0012)和良性肿块(P=0.04)。ADC 截断值为 1.08×10mm/s 时,在混合性或壁结节亚组中,ADC 对识别侵袭性病变的敏感性为 71.4%,特异性为 100%,曲线下面积为 0.92(95%置信区间:0.76-0.99)。
附件肿块实性组织的 ADC 分析有助于鉴别 O-RADS MRI 4 类别的侵袭性肿块,尤其是在混合性肿块或壁结节中。